Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference14 articles.
1. Dasari P. Missing choriocarcinoma may be easy but not suspecting it in a high-risk case can be potentially fatal. Case Rep. 2015;2015:bcr2014208526.
2. Slim R, Coullin P, Diatta A-L, Chebaro W, Courtin D, Abdelhak S, et al. NLRP7 and the genetics of post-molar choriocarcinomas in Senegal. Mol Hum Reprod. 2012;18:52–6.
3. Kalogiannidis I, Kalinderi K, Kalinderis M, Miliaras D, Tarlatzis B, Athanasiadis A. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review. J Assist Reprod Genet. 2018;35:967–73.
4. About Gestational Trophoblastic Disease (GTD) - Dana-Farber Cancer Institute|Boston, MA [Internet]. Cited 2 Nov 2020. https://www.dana-farber.org/gestational-trophoblastic-disease/about/.
5. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38:300–2.